Table 1.
All pediatric cases |
Cases with family history available |
Cases without family history available |
|||||
---|---|---|---|---|---|---|---|
N (%) | N (%) | N (%) | p 1 | ||||
Total | 6,338 | 100.0 | 4,482 | 70.7 | 1,856 | 29.3 | |
Place of birth | |||||||
In Utah | 3,724 | 58.8 | 3,673 | 82.0 | 51 | 2.7 | |
Outside of Utah | 2,614 | 41.2 | 809 | 18.0 | 1,805 | 97.3 | <0.0001 |
Gender | |||||||
Female | 2,962 | 46.7 | 2,130 | 47.5 | 832 | 44.8 | |
Male | 3,376 | 53.3 | 2,352 | 52.5 | 1,024 | 55.2 | |
Year of diagnosis | |||||||
1966–1979 | 1,332 | 21.0 | 930 | 20.7 | 402 | 21.7 | |
1980–1989 | 1,407 | 22.2 | 973 | 21.7 | 434 | 23.4 | |
1990–1999 | 1,697 | 26.8 | 1,225 | 27.3 | 472 | 25.4 | |
2000–2009 | 1,902 | 30.0 | 1,354 | 30.2 | 548 | 29.5 | |
Age at diagnosis | |||||||
0–4 | 2,247 | 35.5 | 1,552 | 34.6 | 695 | 37.4 | |
5–18 | 4,091 | 64.5 | 2,930 | 65.4 | 1,161 | 62.6 | |
Last follow-up year in Utah | |||||||
No Utah follow-up | 1,530 | 24.1 | 104 | 2.3 | 1,426 | 76.8 | |
Same as birth year | 94 | 1.5 | 87 | 1.9 | 7 | 0.4 | |
1–4 years > birth year | 517 | 8.2 | 439 | 9.8 | 78 | 4.2 | |
5+ years > birth year | 4,197 | 66.2 | 3,852 | 85.9 | 345 | 18.6 | <0.0001 |
Vital status | |||||||
Alive at last follow-up | 4,307 | 68.0 | 3,020 | 67.4 | 1,287 | 69.3 | |
Deceased, cancer | 1,185 | 18.7 | 1,052 | 23.5 | 133 | 7.2 | |
Deceased, other/unknown | 846 | 13.3 | 410 | 9.1 | 436 | 23.5 | <0.0001 |
Multiple primary cancers | |||||||
First primary only | 6,167 | 97.3 | 4,340 | 96.8 | 1,827 | 98.4 | |
Multiple primaries | 171 | 2.7 | 142 | 3.2 | 29 | 1.6 | <0.001 |
Total pediatric tumors (ICCC-3) | 6,399 | 100.0 | 4,528 | 71.4 | 1,871 | 29.5 | |
Leukemias, myeloproliferative, myelodisplastic diseases | 1,686 | 26.3 | 1,150 | 25.4 | 536 | 28.6 | <0.01 |
CNS, misc. intracranial and intraspinal neoplasms | 1,270 | 19.8 | 870 | 19.2 | 400 | 21.4 | |
Lymphomas, reticuloendothelial neoplasms | 795 | 12.4 | 578 | 12.8 | 217 | 11.6 | |
Other malignant epithelial neoplasms, malignant melanomas | 584 | 9.1 | 480 | 10.6 | 104 | 5.6 | <0.0001 |
Soft tissue and other extraosseous sarcomas | 425 | 6.6 | 304 | 6.7 | 121 | 6.5 | |
Malignant bone tumors | 403 | 6.3 | 258 | 5.7 | 145 | 7.7 | <0.01 |
Neuroblastoma, other peripheral nervous cell tumors | 377 | 5.9 | 254 | 5.6 | 123 | 6.6 | |
Germ cell tumors, trophoblastic tumors, neoplasms of gonads | 337 | 5.3 | 262 | 5.8 | 75 | 4.0 | <0.01 |
Renal tumors | 291 | 4.5 | 203 | 4.5 | 88 | 4.7 | |
Retinoblastomas | 125 | 2.0 | 87 | 1.9 | 38 | 2.0 | |
Hepatic tumors | 77 | 1.2 | 60 | 1.3 | 17 | 0.9 | |
Not classified or in situ | 29 | 0.5 | 22 | 0.5 | 7 | 0.4 |
Chi-squared test of association between cases with and without genealogy; p-values > 0.01 are not displayed.
Abbreviations: ICCC-3: International Classification of Childhood Cancer, Third edition13; CNS: central nervous system.